CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Wondering who needs long term care insurance at 55? Learn about the key factors that determine your need for coverage.
27,171 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
As July opens, traders are eyeing a quiet market mover. This unheralded sector sure has a track record of supporting ...
Tech-led gains pushed the Nasdaq Composite higher as memory stocks rallied, signaling continued AI-driven demand and ...
As mid-2026 trading picks up, McDonald’s demonstrates stronger growth and cash flow versus Pfizer, which relies on in...
Former NBA star Kris Humphries is growing a Minnesota restaurant portfolio with a goal of 30 Dave’s Hot Chicken locat...
Markets react to political echoes of Jimmy Carter as Trump faces Iran tensions and inflation. This piece explores wha...
NVIDIA is broadening beyond GPUs into physical AI robotics, building a global ecosystem and securing China sales, as ...
A heated public dispute over tariffs erupts after a Supreme Court ruling on emergency tariffs, with Treasury Secretar...
A late 2025 study finds workers would sacrifice up to a quarter of compensation to keep remote work options. The resu...
A weekend strike campaign put the U.S. on center stage as China and Russia offered only verbal condemnations. Markets...
San Francisco rolls out the Year of the Fire Horse parade with Olympic champion Eileen Gu as grand marshal, spotlight...
As XRP trades near $1.43, analysts weigh whether a $10 price is possible and outline the five catalysts and macro con...